September 10, 2025International Journal of Molecular SciencesOpen Access

Muscarinic Receptor Antagonism and TRPM3 Activation as Stimulators of Mitochondrial Function and Axonal Repair in Diabetic Sensorimotor Polyneuropathy

View Full Paper

Ask AI

Bookmark

M1R antagonism promotes mitochondrial function and axonal repair in diabetic sensorimotor polyneuropathy, addressing a critical treatment gap.
Activation of TRPM3 enhances mitochondrial Ca2+ uptake and energy, supporting axonal sprouting and repair processes.
With nearly half of all diabetes patients affected, better treatment approaches for diabetic sensorimotor polyneuropathy are urgently needed.
The strategies discussed may shift focus from mere symptom control to genuine nerve restoration in peripheral neuropathies.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

This review demonstrates M1R antagonism and TRPM3 activation improve mitochondrial function in diabetic sensorimotor polyneuropathy, suggesting new treatment avenues.

Cite This Study

Chauhan et al. (2025) studied this question.

synapsesocial.com/papers/68c241acb210217d6479fd9f https://doi.org/10.3390/ijms26157393

View Full Paper

Ask AI

Bookmark

Implication

This review demonstrates M1R antagonism and TRPM3 activation improve mitochondrial function in diabetic sensorimotor polyneuropathy, suggesting new treatment avenues.

Muscarinic Receptor Antagonism and TRPM3 Activation as Stimulators of Mitochondrial Function and Axonal Repair in Diabetic Sensorimotor Polyneuropathy

Key Points

Discussion

Implication

Cite This Study

Muscarinic Receptor Antagonism and TRPM3 Activation as Stimulators of Mitochondrial Function and Axonal Repair in Diabetic Sensorimotor Polyneuropathy

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider